St. Jude Children’s Research Hospital shared a post on LinkedIn:

“A multinational effort with St. Jude researcher, Marcin Wlodarski and collaborators at the helm created new guidelines for Diamond Blackfan anemia syndrome treatment, helping identify and treat the rare congenital disease using the most recent research and clinical experience. Learn more about those new DBA treatment guidelines in The Lancet Hematology.”

View additional information.
Source: St. Jude Children’s Research Hospital/LinkedIn

St. Jude Children’s Research Hospital, founded in 1962 by Danny Thomas, is a nonprofit institution located in Memphis, Tennessee. Accredited as an NCI cancer center in 1977 and recognized as a comprehensive cancer center in 2008, its primary objective is to advance pediatric cancer cures through research and treatment.

St. Jude is the only NCI-Designated Comprehensive Cancer Center dedicated solely to children. St. Jude integrates specialists and researchers across various disciplines into five collaborative research programs. These programs are structured to make essential scientific discoveries in pediatric cancer biology, translate them into effective treatments for childhood brain tumors, solid tumors, and blood cancers, and address the long-term health outcomes of survivors.

Additionaly, St. Jude aims to make discoveries accessible globally and has developed protocols for pediatric cancer care, tailored for resource-limited settings, to save numerous children’s lives.
OncoDaily